SCHEMBL466503

SCHEMBL466503

CCCCC(CC)CC(C(=O)O)C(CC(CC)CCCC)(C(=O)O)S(=O)(=O)O.[KH]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.36
CA2 P00918 3/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HSPD1 P10809 1/20 0.33
BLM P54132 1/20 0.33
HSPE1 P61604 1/20 0.33
TSHR P16473 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CYP3A4 P08684 1/20 0.33
ATM Q13315 1/20 0.33
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186952 0.99 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
Ammonia Solution, Strong SCHEMBL466472 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
SCHEMBL3797837 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
SCHEMBL20526055 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
SCHEMBL51226 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
SCHEMBL2425805 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
Ammonia Solution, Strong SCHEMBL466470 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
Ammonia Solution, Strong SCHEMBL3975598 0.97 RECQL (0.36) RECQLCA2MAPK1ALDH1A1HSPD1
SCHEMBL18244065 0.95 RECQL (0.34) RECQLCA2MAPK1ALDH1A1HSPD1
Boric Acid SCHEMBL5490022 0.95 RECQL (0.34) RECQLCA2MAPK1ALDH1A1HSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010097643-A1 FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE NOVATECH ISTRAZIVANJE D.O.O. (HR) 2010-09-02 WO claimed
US-7758684-B2 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2010-07-20 US claimed
WO-2010018418-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON NOVATECH D.O.O. (HR) 2010-02-18 WO claimed
US-20070283845-A1 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2007-12-13 US claimed
US-12528935-B2 Latex composition for dip molding and dip-molded article ZEON CORPORATION (JP) 2026-01-20 US disclosed
US-12486384-B2 Latex composition and dip-molded body ZEON CORPORATION (JP) 2025-12-02 US disclosed
US-12421375-B2 Latex composition for dip molding and dip-molded article ZEON CORPORATION (JP) 2025-09-23 US disclosed
US-20250019502-A1 PREPARING METHOD OF POLYMER POWDER FOR BINDER AND BINDER COMPOSITION KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2025-01-16 US disclosed
WO-2023181837-A1 LATEX COMPOSITION AND DIP-MOLDED BODY 日本ゼオン株式会社 2023-09-28 WO disclosed
EP-3543261-B1 SYNTHETIC POLYISOPRENE LATEX ZEON CORP (JP) 2023-09-06 EP disclosed
EP-3520750-B1 METHOD OF MANUFACTURING PACKAGE STRUCTURE ZEON CORP (JP) 2023-05-24 EP disclosed
US-20230151193-A1 LATEX COMPOSITION FOR DIP MOLDING AND DIP-MOLDED ARTICLE ZEON CORPORATION (JP) 2023-05-18 US disclosed
US-20030119794-A1 Novel bretylium compositions and kits and their use in preventing and treating cardiovascular conditions BACANER MARVIN B (US) 2003-06-26 US disclosed
US-20030065015-A1 Novel quarternary ammonium compositions coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions BACANER MARVIN B (US) 2003-04-03 US disclosed
US-6482811-B1 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions BACANER MARVIN B (US) 2002-11-19 US disclosed
EP-1140054-A2 BRETYLIUM COMPOSITIONS AND KITS, AND THEIR USE IN PREVENTING AND TREATING CARDIOVASCULAR CONDITIONS Bacaner, Marvin B. (US) 2001-10-10 EP disclosed
US-6261352-B1 BETAINE, SULFO ESTER THE PILOT INK CO., LTD. (JP) 2001-07-17 US disclosed
WO-2000040232-A2 BRETYLIUM COMPOSITIONS AND KITS, AND THEIR USE IN PREVENTING AND TREATING CARDIOVASCULAR CONDITIONS BACANER MARVIN B (US) 2000-07-13 WO disclosed
EP-0964036-A2 Water-based ball-point pen ink composition THE PILOT INK CO., LTD. (JP) 1999-12-15 EP disclosed
US-4051299-A ALKYLENE OXIDE ADDUCT EMULSIFIER, MONO- OR DI-ESTER OR OIL LUBRICANT FIBER INDUSTRIES INC. (US) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119794-A1 Novel bretylium compositions and kits and their use in preventing and treating cardiovascular conditions TNNT2, TNNI3, FABP3 RECQL 2671/4885CA2 1647/4885MAPK1 3234/4885
US-12528935-B2 Latex composition for dip molding and dip-molded article GLO1, WDR1, PIM1 RECQL 3021/4885CA2 4331/4885MAPK1 922/4885
US-20030065015-A1 Novel quarternary ammonium compositions coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions SLC10A1, ATP6V1B1, SLC7A1 RECQL 748/4885CA2 128/4885MAPK1 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.